FDA Inspection
VitalantVitalant – FDA Inspection, Aug 7, 2024
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on August 7, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f300122d-3b5f-4420-8224-64f4b3e47fc9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1247163
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 14, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 12, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 19, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1076433 - 2018-11-27
- FDA Inspection 999732 - 2016-12-07
- FDA Inspection 911710 - 2015-01-14
- FDA Inspection 810328 - 2012-12-12
- FDA Inspection 720616 - 2011-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.